CompletedPhase 2NCT00998556

Effect of Bromocriptine on Left Ventricular Function in Women With Peripartum Cardiomyopathy

Studying Peripartum cardiomyopathy

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Hannover Medical School
Principal Investigator: Johann Bauersachs, Prof. Dr.
Hannover Medical School, Hannover, Germany
Intervention: Bromocriptine(drug)
Enrollment: 64 target
Eligibility: 18 years · FEMALE
Timeline: 2010 – 2016

Study locations (1)

Hannover Medical School (MHH), Hanover, Lower Saxony, Germany

Collaborators

German Federal Ministry of Education and Research

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00998556 on ClinicalTrials.gov

Other trials for Peripartum cardiomyopathy

Additional recruiting or active studies for the same condition.

See all trials for Peripartum cardiomyopathy →

← Back to all trials